Introduction Semaglutide has rapidly gained recognition as a transformative medication in the treatment of type 2 diabetes and obesity. Initially developed for diabetes management, Semaglutide belongs to a class of drugs known as GLP-1 receptor agonists. These medications mimic the actions of a naturally occurring hormone in the body, glucagon-like https://serpsdirectory.com/listings12991097/semaglutide-a-breakthrough-treatment-for-diabetes-weight-loss-and-cardiovascular-health